EUVIMEDEUVIMED entdecken
Crossref

Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats

The Egyptian Journal of Hospital Medicine · 01.04.2026 · 103 (1) · 1529-1536

DOI: 10.21608/ejhm.2026.496144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Hospital Medicine, online erschienen am 01.04.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats. The Egyptian Journal of Hospital Medicine, 103(1), 1529-1536. https://doi.org/10.21608/ejhm.2026.496144

Vancouver

Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats. The Egyptian Journal of Hospital Medicine. 2026;103(1):1529-1536. doi:10.21608/ejhm.2026.496144

BibTeX
@article{euvimed2026,
  title = {Oxymatrine Mitigates Metabolic Syndrome-Induced Renal Damage Via Upregulation of Nrf2/HO-1 Signaling Pathway in Rats},
  journal = {The Egyptian Journal of Hospital Medicine},
  year = {2026},
  volume = {103},
  number = {1},
  pages = {1529--1536},
  doi = {10.21608/ejhm.2026.496144}
}
Kostenlos starten →